Literature DB >> 17652225

Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow.

Irfan Barutcu1, Alpay Turan Sezgin, Nurzen Sezgin, Hakan Gullu, Ali Metin Esen, Ergun Topal, Ramazan Ozdemir, Feridun Kosar, Sengul Cehreli.   

Abstract

Previous studies have suggested that microvascular abnormalities cause slow coronary flow (SCF). The role of inflammation has not been investigated, to date. The purpose of this study was to determine the role of inflammation in pathogenesis of SCF. The study included 32 patients with angiographically proven SCF (mean age 49 +/-9 years) (group I) and 30 subjects with normal coronary flow (mean age 48 +/-8 years) (group II). Blood samples were collected for high sensitive CRP (hs-CRP) measurements. Thrombolysis in myocardial infarction frame count (TFC) was compared in both groups. Distribution of sex, age, body mass index (BMI), arterial blood pressure, and ejection fraction were similar in the 2 groups. TFC was significantly higher in group I than in group II for each artery including left anterior descending coronary artery (LAD), left circumflex artery (Cx), and right coronary artery (RCA) (38.9 +/-6.6 vs 22.1 +/-1.8 frames, p = 0.0001; 39.6 +/-4.9 vs 22.3 +/-1.8 frames, p = 0.001 ; 39.0 +/-3.8 vs 22.0 +/-1.8 frames, p = 0.001, respectively). In group I, serum hs-CRP concentration was significantly higher than that of group II (0.6 +/-0.58 vs 0.24 +/-0.1 mg/dL p = 0.03). Correlation analysis showed a positive correlation between hs-CRP level and TFC for each artery (for CTFC(LAD), r = 0.36 p = 0.004; for TFC(Cx), r = 0.42 p = 0.003; and for TFC(RCA), r = 0.42, p = 0.0001 respectively). Increased hs-CRP level suggests that inflammation may be associated with pathogenesis of SCF or at least in part contributes to its pathogenesis. Increased hs-CRP level may also be an early marker of impaired coronary blood flow.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652225     DOI: 10.1177/0003319707304943

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  15 in total

1.  Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients.

Authors:  Jiangyan Huang; Qin Yang; Longmiao He; Jun Huang
Journal:  J Clin Lab Anal       Date:  2017-04-13       Impact factor: 2.352

2.  Relationship between serum visfatin levels and coronary slow-flow phenomenon.

Authors:  Huseyin Altug Cakmak; Serkan Aslan; Ahmet Arif Yalcin; Ibrahim Faruk Akturk; Burce Yalcin; Fatih Uzun; Derya Ozturk; Mehmet Erturk; Mehmet Gul
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

3.  Evaluation of Tp-Te Interval and Tp-Te/QT Ratio in Patients with Coronary Slow Flow Tp-Te/QT Ratio and Coronary Slow Flow.

Authors:  Erhan Tenekecioglu; Kemal Karaagac; Osman Can Yontar; Fahriye Vatansever Agca; Ozlem Arican Ozluk; Ahmet Tutuncu; Burhan Arslan; Mustafa Yilmaz
Journal:  Eurasian J Med       Date:  2015-06

4.  Clinical analysis of the risk factors of slow coronary flow.

Authors:  Shuang Xia; Song-Bai Deng; Yang Wang; Jun Xiao; Jian-Lin Du; Yu Zhang; Xi-Chun Wang; Ye-Qing Li; Rui Zhao; Li He; Yu-Luan Xiang; Qiang She
Journal:  Heart Vessels       Date:  2011-01-05       Impact factor: 2.037

5.  Interleukin-10 promotor -592A/C polymorphism is associated with slow coronary flow in Han Chinese.

Authors:  Gui-Liang Shi; Xing-Xing Cai; Ya-Min Su; Chu Chen; Xin-Tao Deng; Hai-Yan Pan; Meng-Kan Fan; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

6.  Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity.

Authors:  E Melles; H Jörnvall; S Tryggvason; K Gemzell Danielsson; K Ekberg; K Tryggvason; J Wahren; T Bergman
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

7.  Association of eosinophil-to-lymphocyte ratio with coronary slow-flow phenomenon in patients undergoing coronary angiography.

Authors:  Aydın Rodi Tosu; Muhsin Kalyoncuoğlu; Halil İbrahim Biter; Sinem Çakal; Beytullah Çakal; Murat Selçuk; Tufan Çinar
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-07-07

8.  Predictors of slow flow in angiographically normal coronary arteries.

Authors:  Ibrahim Altun; Fatih Akin; Nuri Kose; Cem Sahin; Ismail Kirli
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Relationship Between the Reciprocal Change in Inflammation-Related Biomarkers (Fibrinogen-to-Albumin and hsCRP-to-Albumin Ratios) and the Presence and Severity of Coronary Slow Flow.

Authors:  Osman Kayapinar; Cem Ozde; Adnan Kaya
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

10.  Evaluation of plasma eosinophil count and mean platelet volume in patients with coronary slow flow.

Authors:  Mehmet Demir; Selvi Coşar; Mehmet Melek
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.